ClearPoint Neuro (CLPT) Projected to Post Quarterly Earnings on Tuesday

ClearPoint Neuro (NASDAQ:CLPT) is anticipated to announce its earnings results after the market closes on Tuesday, March 11th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.23 million for the quarter. ClearPoint Neuro has set its FY 2025 guidance at EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

ClearPoint Neuro (NASDAQ:CLPT) last released its earnings results on Wednesday, February 26th. The company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). The company had revenue of $7.77 million for the quarter, compared to analysts’ expectations of $8.23 million. ClearPoint Neuro had a negative return on equity of 62.10% and a negative net margin of 59.64%. On average, analysts expect ClearPoint Neuro to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ClearPoint Neuro Stock Down 6.7 %

CLPT stock opened at $13.55 on Tuesday. The stock has a market capitalization of $374.41 million, a P/E ratio of -19.64 and a beta of 1.03. The firm has a 50-day simple moving average of $16.62 and a 200-day simple moving average of $13.91. ClearPoint Neuro has a 52 week low of $5.11 and a 52 week high of $19.22.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on CLPT shares. B. Riley boosted their price target on shares of ClearPoint Neuro from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Tuesday, January 28th. Lake Street Capital boosted their price target on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, January 21st.

About ClearPoint Neuro

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.